Search International and National Patent Collections
Some content of this application is unavailable at the moment.
If this situation persists, please contact us atFeedback&Contact
1. (WO2010077654) COMBINED NATRIURETIC PEPTIDE ASSAYS
Latest bibliographic data on file with the International Bureau

Pub. No.: WO/2010/077654 International Application No.: PCT/US2009/067134
Publication Date: 08.07.2010 International Filing Date: 08.12.2009
IPC:
G01N 33/53 (2006.01)
G PHYSICS
01
MEASURING; TESTING
N
INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
33
Investigating or analysing materials by specific methods not covered by groups G01N1/-G01N31/131
48
Biological material, e.g. blood, urine; Haemocytometers
50
Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
53
Immunoassay; Biospecific binding assay; Materials therefor
Applicants:
ALERE SAN DIEGO, INC. [US/US]; 9975 Summers Ridge Road San Diego, CA 92121, US (AllExceptUS)
LEE, Seok-Won [KR/US]; US (UsOnly)
Inventors:
LEE, Seok-Won; US
Agent:
MCNEMAR, Mark, D.; Wilson Sonsini Goodrich & Rosati 650 Page Mill Road Palo Alto, CA 94304-1050, US
Priority Data:
61/120,79508.12.2008US
Title (EN) COMBINED NATRIURETIC PEPTIDE ASSAYS
(FR) DOSAGES DE PEPTIDES NATRIURÉTIQUES COMBINÉS
Abstract:
(EN) The present invention relates to methods for the diagnosis and evaluation of BNP- related diseases. In particular, patient test samples are analyzed for the presence and amount of a plurality of natriuretic peptides, and a combined natriuretic peptide result is used as a diagnostic marker.
(FR) La présente invention porte sur des procédés pour le diagnostic et l'évaluation de maladies associées au peptide B-natriurétique. En particulier, des échantillons de test de patient sont analysés à la recherche de la présence et de la quantité d'une pluralité de peptides natriurétiques, et un résultat des peptides natriurétiques combinés est utilisé comme marqueur de diagnostic.
Designated States: AE, AG, AL, AM, AO, AT, AU, AZ, BA, BB, BG, BH, BR, BW, BY, BZ, CA, CH, CL, CN, CO, CR, CU, CZ, DE, DK, DM, DO, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, GT, HN, HR, HU, ID, IL, IN, IS, JP, KE, KG, KM, KN, KP, KR, KZ, LA, LC, LK, LR, LS, LT, LU, LY, MA, MD, ME, MG, MK, MN, MW, MX, MY, MZ, NA, NG, NI, NO, NZ, OM, PE, PG, PH, PL, PT, RO, RS, RU, SC, SD, SE, SG, SK, SL, SM, ST, SV, SY, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, ZA, ZM, ZW
African Regional Intellectual Property Organization (ARIPO) (BW, GH, GM, KE, LS, MW, MZ, NA, SD, SL, SZ, TZ, UG, ZM, ZW)
Eurasian Patent Organization (AM, AZ, BY, KG, KZ, MD, RU, TJ, TM)
European Patent Office (AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, SE, SI, SK, SM, TR)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, ML, MR, NE, SN, TD, TG)
Publication Language: English (EN)
Filing Language: English (EN)
Also published as:
EP2376919US20110270530CN102334031CN104198739